BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Pre-tax earnings
Latest
$267.39M
↑ 371% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-98.59M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $267.39M | +407.5% |
| 2024 | $-86.95M | +61.6% |
| 2023 | $-226.23M | +7.4% |
| 2022 | $-244.38M | -34.4% |
| 2021 | $-181.81M | +0.5% |
| 2020 | $-182.81M | -67.9% |
| 2019 | $-108.90M | -7.6% |
| 2018 | $-101.25M | -53.9% |
| 2017 | $-65.78M | -19.3% |
| 2016 | $-55.14M | - |